Title
Il-15 Superagonist and Dinutuximab significantly Enhance Expanded Natural Killer Cell Activity Against Gd2(+) Pediatric Solid Tumors (ST)
Document Type
Abstract
Publication Date
6-2019
Department
Pediatrics
Second Department
Pharmacology
Recommended Citation
Chu, Y., Nayyar, G., Rosenblum, J., Lyngdoh, J., Cao, J., Jeng, E., Alter, S., Rhode, P. R., Amar, S., Lee, D. A., Wong, H. C., Lee, J. H., & Cairo, M. S. (2019). Il-15 Superagonist and Dinutuximab significantly Enhance Expanded Natural Killer Cell Activity Against Gd2(+) Pediatric Solid Tumors (ST). Pediatric Blood & Cancer, 66 (Suppl. 2), 1026. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/275
COinS
